ArticleCureus2019
Hyperprogression in PDL1 Expressive, Recurrent Gastroesophageal-junction Adenocarcinoma After Pembrolizumab.
Shashank Sama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleCureus2019
Shashank Sama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.